Cantor Fitzgerald Reiterates Overweight on Annexon
Annexon Presents Phase 2 ARCHER Data On Protection Of Vision And Photoreceptors With ANX007 In GA At The Retina Society 57th Annual Meeting And 24th Euretina Congress
Annexon Expands Senior Leadership in Commercial, Medical Affairs and Health Economics to Advance Global Late-Stage Neuroinflammatory-Targeted Portfolio
Annexon Biosciences to Participate in Upcoming September Investor Conferences
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
One Annexon Insider Raised Their Stake In The Previous Year